Terms: = Lung cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1 AND Prognosis
43 results:
1. Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells.
Stickler S; Rath B; Hochmair M; Lang C; Weigl L; Hamilton G
Oncol Res; 2023; 31(1):13-22. PubMed ID: 37303738
[TBL] [Abstract] [Full Text] [Related]
2. Downregulation of KIF15 inhibits the tumorigenesis of non-small-cell lung cancer via inactivating Raf/MEK/ERK signaling.
Luo Y; Zhang B; Xu L; Li M; Wu J; Zhou Y; Li Y
Histol Histopathol; 2022 Mar; 37(3):269-285. PubMed ID: 34908156
[TBL] [Abstract] [Full Text] [Related]
3. Impact of thymosin α1 as an immunomodulatory therapy on long-term survival of non-small cell lung cancer patients after R0 resection: a propensity score-matched analysis.
Guo CL; Mei JD; Jia YL; Gan FY; Tang YD; Liu CW; Zeng Z; Yang ZY; Deng SY; Sun X; Liu LX
Chin Med J (Engl); 2021 Nov; 134(22):2700-2709. PubMed ID: 34732663
[TBL] [Abstract] [Full Text] [Related]
4. Down-regulation of RCC1 sensitizes immunotherapy by up-regulating PD-L1 via p27
Zeng X; Zhong M; Yang Y; Wang Z; Zhu Y
J Cell Mol Med; 2021 Apr; 25(8):4136-4147. PubMed ID: 33630417
[TBL] [Abstract] [Full Text] [Related]
5. Retinoblastoma co-repressor 1 (RB) and cyclin-dependent kinase inhibitor (CDKN) as a multi-gene panel for differentiating pulmonary from non-pulmonary origin in metastatic neuroendocrine carcinomas.
Krishnamurthy K; Cusnir M; Schwartz M; Sriganeshan V; Poppiti RJ
Pathol Res Pract; 2020 Sep; 216(9):153051. PubMed ID: 32825935
[TBL] [Abstract] [Full Text] [Related]
6. SOX9 dependent FOXA1 expression promotes tumorigenesis in lung carcinoma.
Wang X; Yin Y; Du R
Biochem Biophys Res Commun; 2019 Aug; 516(1):236-244. PubMed ID: 31221478
[TBL] [Abstract] [Full Text] [Related]
7. ZNF692 promotes colon adenocarcinoma cell growth and metastasis by activating the PI3K/AKT pathway.
Xing Y; Ren S; Ai L; Sun W; Zhao Z; Jiang F; Zhu Y; Piao D
Int J Oncol; 2019 May; 54(5):1691-1703. PubMed ID: 30816443
[TBL] [Abstract] [Full Text] [Related]
8. WT1-interacting protein inhibits cell proliferation and tumorigenicity in non-small-cell lung cancer via the AKT/FOXO1 axis.
Wu Z; Qiu M; Mi Z; Meng M; Guo Y; Jiang X; Fang J; Wang H; Zhao J; Liu Z; Qian D; Yuan Z
Mol Oncol; 2019 May; 13(5):1059-1074. PubMed ID: 30690883
[TBL] [Abstract] [Full Text] [Related]
9. Systematic identification of lincRNA-based prognostic biomarkers by integrating lincRNA expression and copy number variation in lung adenocarcinoma.
Wang L; Zhao H; Xu Y; Li J; Deng C; Deng Y; Bai J; Li X; Xiao Y; Zhang Y
Int J Cancer; 2019 Apr; 144(7):1723-1734. PubMed ID: 30226269
[TBL] [Abstract] [Full Text] [Related]
10. Time of Metastasis and Outcome in Colorectal cancer.
Rahbari NN; Carr PR; Jansen L; Chang-Claude J; Weitz J; Hoffmeister M; Brenner H
Ann Surg; 2019 Mar; 269(3):494-502. PubMed ID: 29064893
[TBL] [Abstract] [Full Text] [Related]
11. Comparisons of prognosis between Surgically and Clinically Diagnosed Idiopathic Pulmonary Fibrosis Using Gap Model: A Korean National Cohort Study.
Lee SH; Kim SY; Kim DS; Kim YW; Chung MP; Uh ST; Park CS; Jeong SH; Park YB; Lee HL; Shin JW; Lee EJ; Lee JH; Jegal Y; Lee HK; Kim YH; Song JW; Park MS
Medicine (Baltimore); 2016 Mar; 95(11):e3105. PubMed ID: 26986154
[TBL] [Abstract] [Full Text] [Related]
12. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
[TBL] [Abstract] [Full Text] [Related]
13. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27kip1 translation.
Zhang Y; Yu JJ; Tian Y; Li ZZ; Zhang CY; Zhang SF; Cao LQ; Zhang Y; Qian CY; Zhang W; Zhou HH; Yin JY; Liu ZQ
Oncotarget; 2015 Sep; 6(28):25441-51. PubMed ID: 26213845
[TBL] [Abstract] [Full Text] [Related]
14. SIRT1 inactivation evokes antitumor activities in NSCLC through the tumor suppressor p27.
Zhu L; Chiao CY; Enzer KG; Stankiewicz AJ; Faller DV; Dai Y
Mol Cancer Res; 2015 Jan; 13(1):41-9. PubMed ID: 25143434
[TBL] [Abstract] [Full Text] [Related]
15. Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis.
Cheriyan VT; Wang Y; Muthu M; Jamal S; Chen D; Yang H; Polin LA; Tarca AL; Pass HI; Dou QP; Sharma S; Wali A; Rishi AK
PLoS One; 2014; 9(4):e93711. PubMed ID: 24690739
[TBL] [Abstract] [Full Text] [Related]
16. Immunohistochemistry evaluation of biomarker expression in non-small cell lung cancer (Pharmacogenoscan study).
Toffart AC; Timsit JF; Couraud S; Merle P; Moro-Sibilot D; Perol M; Mastroianni B; Souquet PJ; Girard N; Jeannin G; Romand P; Chatellain P; Vesin A; Brambilla C; Brambilla E
Lung Cancer; 2014 Feb; 83(2):182-8. PubMed ID: 24388706
[TBL] [Abstract] [Full Text] [Related]
17. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization.
Wang H; Ru Y; Sanchez-Carbayo M; Wang X; Kieft JS; Theodorescu D
Clin Cancer Res; 2013 Jun; 19(11):2850-60. PubMed ID: 23575475
[TBL] [Abstract] [Full Text] [Related]
18. EZH2 promotes malignant behaviors via cell cycle dysregulation and its mRNA level associates with prognosis of patient with non-small cell lung cancer.
Cao W; Ribeiro Rde O; Liu D; Saintigny P; Xia R; Xue Y; Lin R; Mao L; Ren H
PLoS One; 2012; 7(12):e52984. PubMed ID: 23300840
[TBL] [Abstract] [Full Text] [Related]
19. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells.
Kikuchi J; Takashina T; Kinoshita I; Kikuchi E; Shimizu Y; Sakakibara-Konishi J; Oizumi S; Marquez VE; Nishimura M; Dosaka-Akita H
Lung Cancer; 2012 Nov; 78(2):138-43. PubMed ID: 22925699
[TBL] [Abstract] [Full Text] [Related]
20. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract] [Full Text] [Related]
[Next]